Skip to main content

Published locations for VIDEO: Ibrutinib PFS is nearly 3 years in MCL patients who had one prior therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. VIDEO: Ibrutinib PFS is nearly 3 years in MCL patients who had one prior therapy

User login

  • Reset your password
  • /content/video-ibrutinib-pfs-nearly-3-years-mcl-patients-who-had-one-prior-therapy
  • /hematologynews/article/154333/mantle-cell-lymphoma/video-ibrutinib-pfs-nearly-3-years-mcl-patients
  • /oncologypractice/article/154333/mantle-cell-lymphoma/video-ibrutinib-pfs-nearly-3-years-mcl-patients
  • /hematologynews/nhlhub/article/154333/mantle-cell-lymphoma/video-ibrutinib-pfs-nearly-3-years-mcl
  • /hematology-oncology/article/154333/mantle-cell-lymphoma/video-ibrutinib-pfs-nearly-3-years-mcl
  • /b-cell-lymphoma-icymi/article/154333/mantle-cell-lymphoma/video-ibrutinib-pfs-nearly-3-years-mcl